Main page Site map Contacts
 
  Key participant of the project: Moscow State University (MSU) русский       english
 
Biomedical project Skulachev ions
 
Biomedical project Skulachev ions
 








Home »

Новости

24 April 2014
Mitotech S.A., a Luxembourg-based clinical-stage biotechnology company today announced that it has initiated Phase II clinical trial of SkQ1 compound evaluating safety and efficacy of the molecule in patients with moderate to severe dry eye disease.


 


 
 
+7 (495) 939-59-45
E-mail info@skq-project.ru
  2008 made in:
© 2008-2014 Mitoengineering Centre of MSU